Kerlikowske, Karla <br/><br/>
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.  [electronic resource] 

 -  Journal of the National Cancer Institute  May 2010 
 - 627-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djq101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Carcinoma, Ductal, Breast--diagnosis<br/>Carcinoma, Intraductal, Noninfiltrating--chemistry<br/>Case-Control Studies<br/>Cyclin-Dependent Kinase Inhibitor p16<br/>Cyclooxygenase 2--analysis<br/>Disease Progression<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Incidence<br/>Ki-67 Antigen--analysis<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Neoplasm Proteins--analysis<br/>Neoplasm Recurrence, Local--diagnosis<br/>Odds Ratio<br/>Palpation<br/>Predictive Value of Tests<br/>Prognosis<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Survival Analysis<br/>Time Factors<br/>Tumor Suppressor Protein p53--analysis